about
Ligand-specific alphabeta and gammadelta T cell responses in childhood tuberculosisESAT-6 peptide recognition by bovine CD8+ lymphocytes of naturally infected cows in herds from southern Italy.Antigen-specific T cells and cytokines detection as useful tool for understanding immunity against zoonotic infections.Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection.Tuning inflammation in tuberculosis: the role of decoy receptors.Mechanisms underlying lineage commitment and plasticity of human γδ T cellsEndothelial progenitor cells: Are they displaying a function in autoimmune disorders?Detection of natural killer T cells in mice infected with Rickettsia conorii.Anti-16-kilodalton mycobacterial protein immunoglobulin m levels in healthy but purified protein derivative-reactive children decrease after chemoprophylaxis.Timing of activation of CD4+ memory cells as a possible marker to establish the efficacy of vaccines against contagious agalactia in sheep.Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis.Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis.Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells.The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases.Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients.Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients.A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection.Characterization of the apical membrane antigen-1 in Italian strains of Babesia bigemina.Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry.Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.Invariant natural killer T cells treated with rapamycin or transforming growth factor-β acquire a regulatory function and suppress T effector lymphocytes.Granulysin‐Dependent Killing of Intracellular and ExtracellularMycobacterium tuberculosisby Vγ9/Vδ2 T LymphocytesToxocara canis infection induces antigen-specific IL-10 and IFNγ production in pregnant dogs and their puppiesExpansion of intracellular IFN-γ positive lymphocytes during Mycoplasma agalactiae infection in sheepγδ cells involved in contact sensitivity preferentially rearrange the Vγ3 region and require interleukin-7A comparison of the efficacy of commercial and experimental vaccines for contagious agalactia in sheepHLA-Cw4 association with acute lymphoblastic leukaemia in Sicilian patientsThe molecular basis of the low hemolytic activity of C4 molecules from low-C4 mice with IgM-coated erythrocytesIL-5 enhances in vitro and in vivo antigen-specific IgA production in MHC genetically determined low IL-5 responder miceMajor histocompatibility complex regulation of interleukin-5 production in the mouseInduction and tolerization of anti-male CD8+ cytotoxic T lymphocytes by in vivo immunization with an H-Y-derived peptideTCR V alpha chain expression influences reactivity to the hapten TNPBroad clonal heterogeneity of antigen-specific CD4+ T-cells localizing at the site of disease during tuberculosisInterleukin 4 suppresses primary interferon gamma response by T cells immunized in vivo and cultured in vitro with interleukin 2Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapyPatterns of phosphoantigen stimulation of human Vgamma9/Vdelta2 T cell clones include Th0 cytokinesDifferential activation of human gammadelta cells by nonpeptide phosphoantigens
P50
Q28377990-439344CD-3254-481A-A4E4-361EF76F97A8Q34601469-BDDF6A7B-9906-4274-83DF-3D3768B61481Q35779625-5B30D91F-9029-4060-990B-0B3A90DAC54FQ36853424-698D9D44-D412-4240-BCD0-F4B4DBEAFCB3Q37486963-5ED85AE2-5E6C-4A5B-901A-2B748BA1579CQ38053867-E19754DA-0BFF-4609-B44B-5792DC6E929CQ38827773-0148ED5D-3E61-420C-8150-8A8EAA80B050Q40215980-A170CEA7-33E2-4259-AB4C-B5EA632E2745Q41821679-62C9C305-2767-4B30-9B52-50B6ED483E4FQ42278114-C9FFB394-9DC1-44CE-ABEC-A8C72FEA0644Q44258886-7EAFCEA8-6E01-4B91-A608-0FFBEC05FAEAQ44267506-A74B749C-6469-49A9-B4C7-B765676FD6ABQ44575984-14DD80B8-2047-4DAE-B495-F751957A30F5Q44671613-53C8A6B1-AE44-4B83-8672-D9F27898244AQ48124107-4E93E0AF-338F-40AF-819F-23E7B2CD7820Q48168109-E7C2FE5F-CC91-48DD-86CC-2C1D1F91C767Q50619066-F08A34B3-21CE-49A8-A558-80EA70AFD525Q51653675-D442C44A-7681-4C5C-B613-697B821FD765Q51767714-03A3AE76-A42F-4F25-9858-075DCFDD5A82Q52668051-ABD54D77-C9BF-4A9A-8434-AE6F52D1B937Q53533655-4CF85208-D4A0-483D-A5D7-FF340D536830Q53542274-02B8CC69-D8E4-478E-9F53-10A39744FC81Q54255391-5A01F805-745E-4FF6-A892-20C5CBB27A17Q54878303-FBAD8167-5F7B-48C4-A28F-7380A67BD4C7Q56827951-A830A02B-01C5-4059-9C5C-3FD732AD79F3Q56988684-885D711A-09C9-41F6-9B91-721726D0365BQ58854752-0A9F5C35-1BF7-46E0-9394-85EE1DE1EF7CQ61856284-1F91D88B-437B-4897-969C-2F9EAC92097DQ63719438-F39B17F6-D5AD-4E4C-A49A-76E51002B1B4Q67919000-C5C32995-981D-4C58-A345-9EB96E5BAE0EQ69749414-8F6F2439-95F7-4439-AD78-2C17F8C7FC6DQ71700735-893F072E-2CF2-484E-A722-2EFF0AC1116EQ72564607-B8752818-5FA9-459A-A2D7-C0D5EE3FB7D4Q73096999-786A3C40-00D3-49A3-8738-6EFF61F220F6Q73097157-4F73FE81-F6C8-4DDC-970F-E9A318ED44B3Q73100412-AEF30684-482C-4941-8388-998DEB3D9A1BQ73363447-EE8FBAAE-AF0C-45E6-9344-02C2C2437A3AQ73969883-4239CC97-5D2F-45CF-B44D-B149EBFF958AQ74220357-954865E2-BDCC-4693-8659-C5474F9FA08EQ74240738-DD12D94F-3FCC-43F8-814F-7F702184997D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Guido Sireci
@ast
Guido Sireci
@en
Guido Sireci
@es
Guido Sireci
@nl
type
label
Guido Sireci
@ast
Guido Sireci
@en
Guido Sireci
@es
Guido Sireci
@nl
prefLabel
Guido Sireci
@ast
Guido Sireci
@en
Guido Sireci
@es
Guido Sireci
@nl
P106
P1153
57195257187
P31
P496
0000-0002-3969-0155